Similar articles

• Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.

  Aranda JM Jr, Schofield RS, Pauly DF, Cleeton TS, Walker TC, Monroe VS Jr, Leach D, Lopez LM, Hill JA. Aranda JM Jr, et al. Am Heart J. 2003 Feb;145(2):324-9. doi: 10.1067/mhj.2003.50. Am Heart J. 2003. PMID: 12595851 Clinical Trial.
• Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.

  Bayram M, De Luca L, Massie MB, Gheorghiade M. Bayram M, et al. Am J Cardiol. 2005 Sep 19;96(6A):47G-58G. doi: 10.1016/j.amjcard.2005.07.021. Am J Cardiol. 2005. PMID: 16181823 Review.
• Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.

  Arnold LM, Crouch MA, Carroll NV, Oinonen MJ. Arnold LM, et al. Pharmacotherapy. 2006 Aug;26(8):1078-85. doi: 10.1592/phco.26.8.1078. Pharmacotherapy. 2006. PMID: 16863484
• Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma.

  Aranda JM Jr, Woo G, Pauly DF, Rodriguez E, Hill JA, Schofield RS. Aranda JM Jr, et al. J Heart Lung Transplant. 2004 Feb;23(2):260-1. doi: 10.1016/S1053-2498(03)00149-9. J Heart Lung Transplant. 2004. PMID: 14761776
• Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.

  Biswas S, Malik AH, Bandyopadhyay D, Gupta R, Goel A, Briasoulis A, Fonarow GC, Lanier GM, Naidu SS. Biswas S, et al. Curr Probl Cardiol. 2023 Aug;48(8):101245. doi: 10.1016/j.cpcardiol.2022.101245. Epub 2022 May 8. Curr Probl Cardiol. 2023. PMID: 35545181 Review.